Search Results

Kenakin joined Glaxo Inc in RTP where he remained for 25 years through iterations of Glaxo Inc, GlaxoWellcome

Steven Foord Steve Foord trained as a Physiologist and Pharmacologist and worked for Glaxo through to These included the identification of RAMPs (solving some CGRP family issues) and the GABA B, carboxylic

She oversaw an increase of the size of the Department, as well as a quintupling of its NIH funding, in Current areas of interest include Protease Activated Receptor signaling in the cardiovascular system She has received numerous awards, including the Glaxo Cardiovascular Discovery Award, the Distinguished

Crinetics, he was senior director and head of endocrinology and metabolism at Neurocrine Biosciences, Inc he initiated and led the effort to discover and develop orally active, nonpeptide GnRH antagonists, including Prior to Neurocrine, from 1995 to 1998, he co-founded ScienceMedia Inc. to develop eLearning solutions

Pina Cardarelli, CSO for GPCR Therapeutics Inc., based in South Korea, has recently been named President of GPCR Therapeutics, USA, a newly incorporated Biotechnology company in the Bay Area. Prior to this, she held the position of Vice President, at Medarex, Inc . While at BMS and Medarex, she led programs from target ID to clinical development that included, CXCL10 She is an inventor on 39 issued U.S. patents including anti-PD-1 patents, 22 EP patents, and greater

Sexton’s awards include the ASCEPT Lecturer award, Endocrine Society (Australia) Senior Plenary award Sexton is also a co-founder of Septerna Inc. " Patrick Sexton on the web CCeMMP Monash University Dr.

After graduating from UCSD he founded Nanome Inc to build Virtual Reality solutions for Scientists and

(2), Arturo Mancini (1), Raida Jallouli (2), Richard Leduc (2) (1)Domain Therapeutics North America Inc discovery of small molecules for the treatment of inflammatory disorders and cancer at Paraza Pharma Inc Domain Therapeutics North America Inc., Montreal, Quebec, Canada 3. pharmacological targets and contribute to the development of innovative treatments for a range of diseases, including

Juan José Fung is a Principal Scientist at GPCR Therapeutics, Inc , a drug discovery company focused

doctoral training at the Pierre and Marie Curie University in Paris and a short internship at Genentech Inc

Josh Pottel "I lead Molecular Forecaster Inc.

Sexton’s awards include the Australasian Society for Clinical and Experimental Pharmacologists and Toxicologists Sexton is also a co-founder of the San Francisco-based biotechnology company Septerna Inc . Dr.

doctoral training at the Pierre and Marie Curie University in Paris and a short internship at Genentech Inc with an H factor of 79 and 32,000 citations (Google Scholar) and has received several distinctions, including

. 🔒 Grandfather Guarantee, your rate never increases Everything You Need to Master GPCR Science in One

Introduction Drug discovery pipelines increasingly depend on screening platforms designed to identify

Important Information To qualify for the team discount, your group must include at least five members

Premium Access Once approved, every member of your team receives free Premium access for 12 months, including

. ⧖ Hours of Expert Training ↓ Downloadable Resources ◕ New Courses added regularly + All included in every career stage 🚀 Don’t just keep up — lead the way. 🔒 Grandfather Guarantee, your rate never increases

Inclusion matters We welcome diverse voices, experiences, and expertise. Launched our podcast to share expert insights with the scientific community. 2021 2nd Annual Summit Increased Premium Members Include: ✔ Drug hunters at early-stage biotechs ✔ CRO leaders building assays and tools moving into translational work ✔ Teams preparing for fundraising or due diligence Expert Contributors Include Free Membership Includes: ✔ Free version of GPCR Weekly News - straight to your inbox!

. 🔒 Grandfather Guarantee, your rate never increases See all Discount Options Why is it Worth It? Masterclasses cover a variety of track including but not limited to pharmacology foundations, agonists

Van Meir Adhesion GPCR BAI1/ADGRB1 can block IGF1R-mediated growth signalling, increase radiosensitivity

Topics may include: • Receptor efficacy and operational models • Allosteric modulators (PAMs and NAMs

Outside of the lab, Ilana is a leader within her community, spearheading several outreach initiatives including

NMDA receptors are implicated in a number of brain disorders including schizophrenia, autism, and epilepsy

One day as they were catching up, Jacob shared his struggles of managing samples and an incredible amount

) and arrestins as GPCR regulators and as mediators of distinct signaling pathways through partners including In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical

In addition to paradigm shifts including inverse agonism, biased signaling, and pharmacological chaperones Michel’s scientific contributions were recognized by the attribution of many awards and distinctions including

In addition to paradigm shifts including inverse agonism, biased signaling, and pharmacological chaperones Michel’s scientific contributions were recognized by the attribution of many awards and distinctions including

Ray Stevens in 2013 solving several GPCR crystal structures, including that of the first serotonin receptor

He is author of over 100 papers, including several in Nature, Science and Cell.